Mergers & Acquisitions - Pharmaceutical

Filter

Current filters:

Pharmaceutical

Popular Filters

1 to 25 of 656 results

EXPERT VIEW: Pfizer and AstraZeneca, a marriage not to be – yet?

EXPERT VIEW: Pfizer and AstraZeneca, a marriage not to be – yet?

19-08-2014

Mergers and acquisitions may excite the markets and shareholders on both sides but their record of success…

GlobalInterviewsMergers & AcquisitionsPharmaceutical

Roche said to be eyeing full control of Chugai

Roche said to be eyeing full control of Chugai

18-08-2014

Although the Swiss drug major has not issued a confirmation, media reports say Roche is close to acquiring…

Business FinanceChugai PharmaceuticalChugai Pharmaceutical Co.Chugai PharmaceuticalsHoffmann-La RocheInvestmentMergers & AcquisitionsPharmaceuticalRoche

$260.2 billion-worth of deals in the global PMB industry in first-half 2014

$260.2 billion-worth of deals in the global PMB industry in first-half 2014

12-08-2014

Global pharma, medical and biotechnology (PMB) M&A activity during the first half of 2014 hit the highest…

Business FinanceGlobalMergers & AcquisitionsPharmaceutical

Allergan and Valeant receive second request for information from US Federal Trade Commission

Allergan and Valeant receive second request for information from US Federal Trade Commission

12-08-2014

US Botox maker Allergan has received a request for additional information from the US Federal Trade Commission…

AllerganBusiness FinanceMergers & AcquisitionsPharmaceuticalUSAValeant PharmaceuticalsValeant Pharmaceuticals International

Sun Pharma’s takeover of Ranbaxy comes to attention of Competition Commission

Sun Pharma’s takeover of Ranbaxy comes to attention of Competition Commission

11-08-2014

The deal between Indian generics company Sun Pharmaceutical Industries which acquired fellow Indian drug…

CCIGenericsIndiaMergers & AcquisitionsPharmaceuticalRanbaxy LaboratoriesSun Pharmaceutical Industries

Walgreens to buy remainder of Boots Alliance, but shuns inversion

06-08-2014

US pharmacy giant Walgreen has exercised its option to buy the remaining 55% of European pharmacy retailer…

Alliance BootsEuropeMarkets & MarketingMergers & AcquisitionsPharmaceuticalWalgreens

Kyowa Hakko Kirin subsidiary ProStrakan acquires Archimedes

Kyowa Hakko Kirin subsidiary ProStrakan acquires Archimedes

06-08-2014

Japanese drugmaker Kyowa Hakko Kirin subsidiary, the Scotland-based ProStrakan, has acquired Archimedes…

ArchimedesArchimedes PharmaFentanylJapanKyowa Hakko KirinMergers & AcquisitionsNovo A/SNovo NordiskPharmaceuticalProStrakan

Allergan attacks Valeant’s financial results

Allergan attacks Valeant’s financial results

06-08-2014

US Botox maker Allergan, the subject of a hostile $53 billion takeover attempt by Canada’s Valeant…

AllerganBusiness FinanceCanadaFinancialMergers & AcquisitionsPharmaceuticalUSAValeant PharmaceuticalsValeant Pharmaceuticals International

Allergan sues Valeant and Pershing Square, alleging insider trading

Allergan sues Valeant and Pershing Square, alleging insider trading

02-08-2014

US Botox maker Allergan, the subject of a hostile $53 billion takeover attempt by Canada’s Valeant…

AllerganBusiness FinanceLegalMergers & AcquisitionsPharmaceuticalUSAValeant Pharmaceuticals International

Altacor growth to accelerate after acquisition by Esperante

Altacor growth to accelerate after acquisition by Esperante

01-08-2014

The private, Netherlands-based life science investment company Esperante says it has completed the acquisition…

AltacorDean SlagelEsperanteIn vitro diagnosticsMergers & AcquisitionsNetherlandsNicOxNYSE EuronextOphthalmicsPharmaceuticalProducerUK

Meda in $3.1 billion deal to acquire Italy’s Rottapharm

Meda in $3.1 billion deal to acquire Italy’s Rottapharm

31-07-2014

Sweden’s Meda says it has entered into a definitive agreement to acquire Rottapharm Madaus, an Italian…

Business FinanceItalyMedaMergers & AcquisitionsMergers and acquisitionsPharmaceuticalRottapharm MadausSwedenSweden

Pfizer spends $635 million on acquiring two Baxter vaccines

Pfizer spends $635 million on acquiring two Baxter vaccines

30-07-2014

US pharma giant Pfizer has entered into a definitive agreement to acquire Baxter International portfolio…

Baxter InternationalMergers & AcquisitionsPfizerPharmaceuticalProductionUSAVaccines

AstraZeneca to acquire Almirall’s respiratory franchise, for up to $2.1 billion

AstraZeneca to acquire Almirall’s respiratory franchise, for up to $2.1 billion

30-07-2014

Anglo-Swedish pharma major AstraZeneca has entered an agreement to gain rights to the respiratory franchise…

AlmirallAstraZenecaEkliraMergers & AcquisitionsPharmaceuticalRespiratory and Pulmonary

PaxVax acquires the FDA-approved typhoid vaccine Vivotif

PaxVax acquires the FDA-approved typhoid vaccine Vivotif

29-07-2014

Privately-held California, USA-based specialty vaccine firm PaxVax says it has acquired the oral typhoid…

LicensingMergers & AcquisitionsPaxVaxPharmaceuticalProductionSwitzerlandVaccinesVivotif

Reckitt Benckiser to spin out pharma; GSK views Consumer options

Reckitt Benckiser to spin out pharma; GSK views Consumer options

28-07-2014

UK-based consumer goods giant Reckitt Benckiser plans to spin off its USA-based pharmaceutical business,…

FinancialGlaxoSmithKlineMergers & AcquisitionsNeurologicalPharmaceuticalReckitt BenckiserSuboxoneUK

Retrophin proposes acquisition of Clinuvel Pharma for $95 million

Retrophin proposes acquisition of Clinuvel Pharma for $95 million

28-07-2014

The USA’s Retrophin has submitted an unsolicited $95 million takeover proposal to the board of directors…

AfamelanotideAustraliaClinuvel PharmaceuticalsDermatologicalsMergers & AcquisitionsPharmaceuticalRare diseasesRetrophinScenesse

Stallergenes expands in Latin American with acquisition of Alergo Pharma

Stallergenes expands in Latin American with acquisition of Alergo Pharma

22-07-2014

French allergen specialist Stallergenes said this morning that it has acquired full ownership of Alergo…

Alergo PharmaAllergologyArgentinaImmunologyMedicineMergers & AcquisitionsPharmaceuticalRespiratory and PulmonaryStallergenes

Shire finally accepts AbbVie’s takeover offer

Shire finally accepts AbbVie’s takeover offer

18-07-2014

After a protracted and at times hostile courtship, Ireland-headquartered drugmaker Shire has finally…

AbbVieHumiraMergers & AcquisitionsNeurologicalPharmaceuticalRare diseasesShireUSA

Shire succumbs to AbbVie’s yet again increased offer of £53.20 per share

Shire succumbs to AbbVie’s yet again increased offer of £53.20 per share

14-07-2014

Ireland-headquartered Shire, which just on Friday confirmed it had finally entered talks with suitor…

AbbVieAdalimumabFinancialIrelandMergers & AcquisitionsPharmaceuticalShireUSA

UK Business Secretary to set out new takeover rules

UK Business Secretary to set out new takeover rules

13-07-2014

UK Business Secretary Vince Cable is shortly to announce new regulations to deal with foreign takeover…

LegalMergers & AcquisitionsPfizerPharmaceuticalUKVince Cable

Shire confirms it has entered into talks with AbbVie

Shire confirms it has entered into talks with AbbVie

12-07-2014

Following reports by the Bloomberg news service, on Friday Ireland-based drugmaker Shire confirmed that…

AbbVieIrelandMergers & AcquisitionsNeurologicalPharmaceuticalRare diseasesShireUSA

Stada Arz acquires Flexitol rights for UK and Ireland

Stada Arz acquires Flexitol rights for UK and Ireland

10-07-2014

Thornton & Ross, the UK subsidiary of German generic and branded drugmaker Stada Arzneimittel, has purchased…

DermatologicalsFlexitolIrelandMergers & AcquisitionsPharmaceuticalSTADA ArzneimittelThornton & RossUK

MabVax Therapeutics and Telik close merger

MabVax Therapeutics and Telik close merger

09-07-2014

USA-based MabVax Therapeutics, a privately held cancer immunotherapy company, and Telik, a publicly-traded…

MabVax TherapeuticsMergers & AcquisitionsOncologyPharmaceuticalTelikUSA

1 to 25 of 656 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top